Mass Spectrometry Market Analysis: Trends, Innovations, and Growth Forecasts

Mass Spectrometry Market in terms of revenue was estimated to be worth $5.4 billion in 2023 and is poised to reach $7.8 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and growing government initiatives for pollution control and environmental testing are high growth prospects for the mass spectrometry market during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437

Mass Spectrometry Market Scope:

Report Coverage	Details
Market Revenue in 2023	$5.4 billion
Estimated Value by 2028	$7.8 billion
Growth Rate	Poised to grow at a CAGR of 7.5%
Market Size Available for	2021–2028
Forecast Period	2023–2028
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product, Sample Preparation Technique, Application, End User, and Region
Geographies Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Report Highlights	Updated financial information / product portfolio of players
Key Market Opportunities	Growth opportunities in emerging countries
Key Market Drivers	Increasing R&D investments in the pharmaceutical and biotechnology industry

Instruments segment to register significant growth rate over the forecast period of 2023-2028

Based on the product, the mass spectrometry is segmented into instrument and software & services. Instruments segment to register significant growth rate over the forecast period of 2023-2028. Advantages offered by instruments, such as rapid and high-resolution testing abilities with more accurate and precise results, are increasing its adoption. Consequently, the demand for mass spectrometry devices for high throughput screening is also growing. The instrument segment is further divided into hybrid mass spectrometry, single mass spectrometry and other technologies.

LC-MS segment accounted for the largest share of the mass spectrometry in 2023-2028

Based on sample preparation technique, the mass spectrometry is segmented into GC-MS, LC-MS, ICP-MS, and others. The LC-MS segment is estimated to hold the largest market share of the mass spectrometry market during the forecast period. The large share of this segment can be attributed to its ability to identify and measure a broader range of compounds with minimal sample preparation. LC-MS can identify a broader range of compounds. LC-MS is applied in many industries such as pharmaceuticals, biopharmaceuticals, forensic, industrial, food and environmental sector. For clinical research, the analysis of drugs, vitamins and minerals in whole blood, plasma, serum and urine is conducted routinely using LCMS. It is a more sensitive instrument.

OMICS research segment accounted for the largest share of the mass spectrometry in 2023-2028

Based on application, the mass spectrometry is segmented into OMICS research, drug discovery, environmental testing, food testing, pharma-biopharma manufacturing, clinical diagnostics, applied industries, and other applications. The OMICS research segment is estimated to hold the largest market share of the mass spectrometry market during the forecast period. The large share of this segment can be attributed to the increasing application of omics technology in diagnostics & biomarker identification and the increasing R&D expenditure and government funding for proteomics are expected to drive the market for this segment.

Pharmaceutical companies’ segment to register for the highest growth rate of the mass spectrometry in 2023-2028

The major end users in the mass spectrometry market are pharmaceutical companies, biotechnology companies, research labs & academic institutes, environmental testing labs, F&B industry, forensic labs, petrochemical industry and other end users. Pharmaceutical companies are expected to dominate the market during the forecast period. The availability of government and corporate funding for pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are some of the key factors driving the growth of this segment during the forecast period.

Asia Pacific to register a significant growth in the market during the forecast period

In 2023, Asia Pacific is expected to register a significant growth in the market during the forecast period. Asia Pacific comprises the China, Japan, India, South Korea, Australia, ASEAN Region, rest of APAC. Factors such as the significant funding for mass spectrometry and environmental monitoring regulations are driving the growth of the Asia Pacific mass spectrometry market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=437

Mass Spectrometry Market Dynamics:

Drivers:

Technological advancements in mass spectrometers
Government initiatives for pollution control and environmental testing
Increasing spending on pharmaceutical R&D
Government regulations on drug safety
Growing focus on quality of food products
Increase in crude and shale gas production

Restraints:

Premium Product Pricing

Opportunities:

Growing opportunities in emerging markets

Challenges:

Dearth of Skilled Professionals

Key Market Players:

The mass spectrometry business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global mass spectrometry market are SCIEX AB (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Waters Corporation (US), PerkinElmer Inc. (US), Shimadzu Corporation (Japan) and Bruker Corporation (US) among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=437

Recent Developments:

In January 2022, Thermo Fisher and Symphogen extended their collaborative partnership with aim to deliver workflows for simplified characterization and quality monitoring of complex therapeutic proteins using the Thermo Scientific Q Exactive Plus Orbitrap LC-MS/MS system.
In February 2023, SCIEX announced collaboration with HighRes Biosolutions to bring customizable automation solutions powered by Cellario software, which would add automation benefits to the Echo MS system.
In February 2022, Waters Corporation acquired Charge Detection Mass Spectrometry technology assets and intellectual property rights of Megadalton Solutions, Inc., to broaden its application in Cell and Gene Therapy.
In September 2022, Agilent Technologies partnered with MOBILion Systems for ion mobility separation technology called Structures for Lossless Ion Manipulation (SLIM) on its Q-TOF mass spectrometers.

Mass Spectrometry Market Advantages:

High Sensitivity: Mass spectrometry is known for its exceptional sensitivity, enabling the detection and quantification of trace amounts of analytes in complex samples. It can identify and quantify molecules at extremely low concentrations, making it invaluable in fields such as environmental analysis, clinical diagnostics, and drug discovery.
Structural Characterization: Mass spectrometry provides detailed structural information about molecules, allowing researchers to determine their composition, fragmentation patterns, and molecular weight. This capability is essential in the identification and characterization of unknown compounds, the elucidation of molecular structures, and the study of complex biological systems.
Versatility and Range of Applications: Mass spectrometry has a broad range of applications across various industries and scientific disciplines. It is utilized in pharmaceutical analysis, proteomics, metabolomics, environmental monitoring, forensic analysis, food safety, and many other fields. Its versatility stems from the ability to analyze diverse analytes, including small molecules, proteins, peptides, lipids, and complex mixtures.
Quantitative Analysis: Mass spectrometry enables quantitative analysis by measuring the abundance of analytes in a sample. It can be used for accurate determination of drug concentrations in biological samples, monitoring the levels of pollutants in environmental samples, and assessing metabolic changes in biological systems. The quantitative capabilities of mass spectrometry are vital for research, quality control, and clinical applications.
High Selectivity: Mass spectrometry offers high selectivity, allowing for the precise identification and differentiation of analytes even in complex matrices. By measuring the unique mass-to-charge ratio of ions, mass spectrometry can distinguish between closely related compounds, isotopes, and different chemical species. This selectivity is particularly valuable in the analysis of complex samples with potential interferences.
Rapid and High-Throughput Analysis: Recent advancements in mass spectrometry technology have enabled rapid data acquisition and high-throughput analysis. Mass spectrometers equipped with advanced hardware and software can quickly analyze large sample sets, providing fast and reliable results. This capability is essential for applications that require high sample throughput, such as clinical diagnostics and drug discovery.
Advancements in Data Analysis: Mass spectrometry generates large volumes of complex data, and advancements in data analysis tools and algorithms have made it easier to process and interpret this information. Techniques such as machine learning and artificial intelligence are being applied to mass spectrometry data, enabling automated data processing, pattern recognition, and faster identification of analytes.

In summary, the mass spectrometry market offers high sensitivity, structural characterization, versatility, quantitative analysis, selectivity, rapid analysis, and advancements in data analysis. These advantages make mass spectrometry a powerful analytical tool with applications across a wide range of industries and scientific disciplines.

Mass Spectrometry Market – Report Highlights:

In this report, mass spectrometry are considered, along with tables and accessories, used for healthcare applications pharmaceutical industries. In this version of the report, two new segments are added— application—for a better and deeper understanding of the market.
The study consists of the average selling price (ASP) analysis for different products in the mass spectrometry market.
The research study comprises the patent analysis of technologies/solutions used in the mass spectrometry market.
The new market study consists of the trends/disruptions impacting customers’ businesses.
The new market study consists of information on key conferences & events in 2021–2023.
The new market study consists of the region-wise regulatory landscape.
The new market study consists of Porter’s Five Forces Analysis
The new market study provides details of the strategies of the top 14 players operating in the market.
The competitive landscape chapter has been updated with the market evaluation matrix. The competitive landscape also includes the market share analysis of major global players (as of 2022), updated competitive leadership mapping, and competitive situations and trends.
The new market study comprises 28 players. These companies have emerged as key market players in recent years due to their products and various strategic investments undertaken in the mass spectrometry market space.
Updated financial information/product portfolio of players: The new edition of the report provides updated financial information in the context of the mass spectrometry market from 2022 to May 2023 (depending on availability) for each listed company in graphical representation.
Updated market developments of profiled players: The current report includes the market developments from January 2019 to May 2023